Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
0.400
+0.018 (4.68%)
At close: Dec 20, 2024, 4:00 PM
0.399
-0.001 (-0.15%)
After-hours: Dec 20, 2024, 5:59 PM EST
Spruce Biosciences Revenue
Spruce Biosciences had revenue of $602.00K in the quarter ending September 30, 2024, a decrease of -80.41%. This brings the company's revenue in the last twelve months to $7.10M, down -1.40% year-over-year. In the year 2023, Spruce Biosciences had annual revenue of $10.09M.
Revenue (ttm)
$7.10M
Revenue Growth
-1.40%
P/S Ratio
2.31
Revenue / Employee
$244,862
Employees
29
Market Cap
16.52M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
The Oncology Institute | 378.93M |
Nephros | 13.55M |
ProPhase Labs | 12.75M |
Synlogic | 2.78M |
Innovative Eyewear | 1.56M |
Traws Pharma | 226.00K |
SPRB News
- 10 days ago - Penny Stock Spruce Biosciences Winds Down Tildacerfont Studies For Rare Genetic Disorder - Benzinga
- 11 days ago - Spruce Biosciences to wind down investment for genetic disorder drug - Reuters
- 11 days ago - Spruce Biosciences Announces Topline Results from CAHmelia-204 in Adult CAH and CAHptain-205 in Adult and Pediatric CAH - Business Wire
- 5 weeks ago - Spruce Biosciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates - Business Wire
- 6 weeks ago - Spruce Biosciences, Inc. Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Affected Shareholders To Reach Out - Accesswire
- 6 weeks ago - Investors Are Invited To Join The Schall Law Firm In An Inquiry Into Spruce Biosciences Inc For Securities Law Violations - Accesswire
- 7 weeks ago - Spruce Biosciences, Inc. Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Affected Shareholders To Take Part - Accesswire
- 7 weeks ago - Investors With Losses Are Invited To Join The Schall Law Firm's Inquiry Into Spruce Biosciences Inc For Possible Securities Law Violations - Accesswire